Carbetocin
- Generic Name
- Carbetocin
- Brand Names
- Duratocin
- Drug Type
- Small Molecule
- Chemical Formula
- C45H69N11O12S
- CAS Number
- 37025-55-1
- Unique Ingredient Identifier
- 88TWF8015Y
- Background
Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.
- Indication
Used to control postpartum hemorrhage and bleeding after giving birth.
- Associated Conditions
- Postpartum Haemorrhage (PPH), Uterine Atony
- Associated Therapies
- -
Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption
- Conditions
- Interventions
- First Posted Date
- 2013-04-09
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- Wafaa Uthman Ahmed
- Target Recruit Count
- 140
- Registration Number
- NCT01827124
- Locations
- 🇪🇬
Ain Shams university maternity hospital department of obstetrics and gynacology, Cairo, Tertiary, Egypt
Carbetocin at Cesarean Delivery for Labor Arrest
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2013-05-30
- Target Recruit Count
- 40
- Registration Number
- NCT01725243
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin
- Conditions
- Interventions
- First Posted Date
- 2012-11-01
- Last Posted Date
- 2015-02-27
- Lead Sponsor
- Universiti Kebangsaan Malaysia Medical Centre
- Target Recruit Count
- 50
- Registration Number
- NCT01719952
- Locations
- 🇲🇾
Department of O&G, Cheras, Kuala Lumpur, Malaysia
Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2012-09-21
- Target Recruit Count
- 20
- Registration Number
- NCT01689298
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Carbetocin at Elective Cesarean Delivery Part 3
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2013-05-30
- Target Recruit Count
- 40
- Registration Number
- NCT01651130
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Laval University
- Target Recruit Count
- 72
- Registration Number
- NCT01630187
- Locations
- 🇨🇦
Hôpital Saint-François-d'Assise (CHUQ), Quebec, Canada
Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
- Conditions
- Interventions
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Sohag University
- Target Recruit Count
- 300
- Registration Number
- NCT01600612
- Locations
- 🇪🇬
Sohag university, Sohag, Egypt
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01579201
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Carbetocin at Elective Cesarean Delivery Part 2
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2012-03-26
- Target Recruit Count
- 120
- Registration Number
- NCT01428817
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
- Conditions
- Interventions
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2015-01-05
- Lead Sponsor
- Saint Thomas Hospital, Panama
- Target Recruit Count
- 636
- Registration Number
- NCT01382732
- Locations
- 🇵🇦
Saint Thomas H, Panama, Panama
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.